| Title |
Vitamin K for improved anticoagulation control in patients receiving warfarin
|
|---|---|
| Published in |
Cochrane database of systematic reviews, May 2014
|
| DOI | 10.1002/14651858.cd009917.pub2 |
| Pubmed ID | |
| Authors |
Kamal R Mahtani, Carl J Heneghan, David Nunan, Nia W Roberts |
| Abstract |
Effective use of warfarin involves keeping the international normalised ratio (INR) within a relatively narrow therapeutic range. However, patients respond widely to their dose of warfarin. Overcoagulation can lead to an increased risk of excessive bleeding, while undercoagulation can lead to increased clot formation. There is some evidence that patients with a variable response to warfarin may benefit from a concomitant low dose of vitamin K. |
Twitter Demographics
The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 33% |
| France | 1 | 17% |
| Unknown | 3 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 83% |
| Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 152 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Iran, Islamic Republic of | 1 | <1% |
| Japan | 1 | <1% |
| Colombia | 1 | <1% |
| Denmark | 1 | <1% |
| Unknown | 148 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 29 | 19% |
| Student > Master | 27 | 18% |
| Researcher | 16 | 11% |
| Student > Postgraduate | 12 | 8% |
| Student > Ph. D. Student | 9 | 6% |
| Other | 22 | 14% |
| Unknown | 37 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 62 | 41% |
| Nursing and Health Professions | 18 | 12% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 8% |
| Biochemistry, Genetics and Molecular Biology | 5 | 3% |
| Agricultural and Biological Sciences | 3 | 2% |
| Other | 13 | 9% |
| Unknown | 39 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 July 2023.
All research outputs
#1,667,780
of 24,145,400 outputs
Outputs from Cochrane database of systematic reviews
#3,751
of 12,846 outputs
Outputs of similar age
#16,891
of 231,146 outputs
Outputs of similar age from Cochrane database of systematic reviews
#73
of 232 outputs
Altmetric has tracked 24,145,400 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,846 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.9. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 231,146 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 232 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.